Pantoprazol Mepha (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Mepha, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Mepha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates healing of erosions caused by acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional mild upset. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Acute interstitial nephritis: kidney inflammation with reduced function. - Severe hypersensitivity: rash, itching, swelling or anaphylaxis. - Osteoporosis‑related fractures: increased risk with long‑term use. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat.

When prescribing Pantoprazol Mepha, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term therapy: evaluate need for continued use after 8‑12 weeks. - Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare professional. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Mepha may interact with several medicines. Clinical relevance varies:

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption leading to therapeutic failure. - Atazanavir: decreased plasma concentrations, compromising HIV treatment efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Digoxin: slight increase in serum levels; observe for toxicity signs. - Methotrexate: reduced renal clearance may raise toxicity risk. - Clopidogrel: diminished antiplatelet effect; consider alternative therapy.